WHO ICTRP trial
Early clinical trials on evaluating the tolerance, safety and efficacy of…
ChiCTR2000035679 · Chinese Clinical Trial Registry (ChiCTR)
Key facts
| Trial ID | ChiCTR2000035679 |
|---|---|
| Public title | Early clinical trials on evaluating the tolerance, safety and efficacy of autologous TILs in high-risk recurrent primary hepatocellular carcinoma |
| Scientific title | A clinical study in patients with high-risk recurrent primary hepatocellular carcinoma Using autologous TILs |
| Primary sponsor | The Third Affiliated Hospital of The Second Military Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Hepatocellular carcinoma |
| Interventions | High dose group: 10^10 TIL;Low dose group: 10^9 TIL |
| Registration date | Aug 16, 2020 |
| Target size | High dose group:6;Low dose group:6 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: